lymphoblastic lymphomas
Image Gallery
[ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma}) ] [ (||image_reduire{0,60}|inserer_attribut{alt,Precursor B lymphoblastic lymphoma (osseous localization)}) ]
Subtypes
precursor B lymphoblastic lymphoma (CD20+, CD19+ or CD79a+)
precursor T lymphoblastic lymphoma (surface CD3+),
non-B, non-T lymphoblastic lymphoma (B cell marker- and surface CD3-).
- CD7+ stem cell lymphoma (CD7+SCL) [CD4-, CD7+, CD33+/-, CD56-]
- blastic natural killer cell lymphoma (B-NKL) [CD4-, CD7+/-, CD33-, CD56+, CD123-]
- myeloid/NK precursor cell leukemia (M/NKL) [CD4-, CD7+, CD33+, CD56+], and 4)
- CD4+ CD56+ hematodermic malignancy (CD4+ CD56+) type [CD4+, CD7+/-, CD33-, CD56+, CD123+]
See also
lymphoblastic leukemias
References
Karube K, Ohshima K, Tsuchiya T, Yamaguchi T, Suefuji H, Suzumiya J, Harada M, Kikuchi M. Non-B, non-T neoplasms with lymphoblast morphology: further clarification and classification. Am J Surg Pathol. 2003 Oct;27(10):1366-74. PMID: #14508398#